serum
-
not specified
RT-qPCR; Clinical Sample Validation; ROC Analysis
Diagnostic biomarker potential in serum; ROC AUC 0.787 for breast cancer detection; combined with Circ-ELP3 improves AUC to 0.891
In this case-control cohort, serum Circ-FAF1 (hsa_circ_100219) is reduced in pre-treatment breast cancer patients and increases after treatment. It has diagnostic value by ROC analysis and enhances diagnostic performance when combined with Circ-ELP3.
0.4187
Serum Circ-FAF1/Circ-ELP3: A novel potential biomarker for breast cancer diagnosis.
clinical study